Phase 3 Crohn's Disease and Colitis Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults between 18 and 75 years of age, of any gender.
- People who are able to read and sign a consent form agreeing to take part in the study.
- People who have had a confirmed diagnosis of ulcerative colitis for at least 90 days before the screening visit.
- People whose ulcerative colitis is rated at a moderate level of activity based on a specific scoring system used by doctors, including visible signs of inflammation on a camera examination of the bowel and some rectal bleeding (confirm with trial site).
- People whose ulcerative colitis has not responded well enough to, stopped responding to, or who could not tolerate at least one approved treatment for ulcerative colitis.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a very severe or rapidly worsening form of ulcerative colitis that is likely to need hospital admission or surgery.
- People who have been diagnosed with Crohn's disease or a type of bowel inflammation that is not ulcerative colitis.
- People who have previously taken a type of medication known as an S1P receptor modulator (confirm with trial site).
- People who currently have an active infection or a long-term ongoing infection.
- People who have a serious heart condition, liver condition, or another major uncontrolled illness affecting the body.
- People who have had an allergic reaction or significant sensitivity to any ingredient in the study medication.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 202-734-3400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical Remission at Week 16
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.